Unilife Corp ($UNIS) - Innovative Drug Delivery Device Solutions

Innovative Drug Delivery Device Solutions
Ramin Mojdeh, Ph.D.
Executive Vice President and
Chief Operating Officer
UBS Specialty Pharma Conference
May 2011

Cautionary Note Regarding Forward-Looking Statements
This presentation contains forward looking statements under the safe harbor provisions of the US securities laws. These forward-looking statements are based on management’s beliefs and assumptions and on information currently available to our management. Our management believes that these forward-looking statements are reasonable as and when made. However you should not place undue reliance on any such forward looking statements as these are subject to risks and uncertainties. Please refer to our press release and our SEC filings for more information regarding the use of forward looking statements.
2

Introducing Unilife
Emerging global leader in innovative drug delivery device solutions
Enable and enhance delivery of drugs by pharmaceutical customers
Rapidly expanding pipeline being driven by customer needs
Unifill– world’s only prefilled platform with integrated safety
NASDAQ listed (UNIS) with state-of-the-art facility in York, PA
3

Attractive Market Trends and Opportunity
$30B Injectable drug delivery device market in2015, 12.3%CAGR
Large macromolecule composition of pharmaceutical pipeline
Safety legislation and sharps management
Devices drive patient acceptance, preference and adherence
Emerging healthcare needs of aging global population
Risingglobalhealthcarestandardscreatingstrongmarketpotential
Improved outcomes and economics with use of unit-dose and ready to administer formats
Trend to patients self-administration of injectable drugs
Patent cliff - 30 biologics with $51B sales expire by 2015
4

Strategic Focus
Innovative devicesolutionsforcommercialdrugs/biosimilars
Integratedproprietaryprimarydrug delivery devices withvalue-addfeatures
Target and address emerging unmet needs for pipeline drugs
Pharmaceuticalcollaborations – specializeddevicesfornoveldrugs
Targethigh-endofmarketfordifferentiateddevices, highmargins
Strategic sourcing of components
In-house manufacturing and final assembly
5

Customer-Driven Technology Pipeline
Technology pipeline developed in partnership with customers
Directly responding to emerging customer needs including:
Integrated primarydrugdelivery devices withvalue-addfeaturesandcustomization
Advanced syringe systems with integrated safety and transfer mechanisms
Dry drug reconstitution and delivery technologies
Large-volume viscous drugs delivery technologies
Targeted organ delivery devices
Multi-chamber proprietary primary containers and delivery systems
Reusable and disposable self administration device technologies
Technology portfolio can be leveraged to develop customized device concepts according to specific customer needs
6

7
Unifill – The Leading Edge of Our Portfolio
World’s first and only prefilled syringes with integrated safety
Now in production
Controlled retraction into barrel
Needle locked after use for convenient, compact disposal

Unifill as a Game Changer
Primary drug delivery device with integrated safety
Direct substitute for current prefill and safety prefill syringes
Powerful brand differentiation
Streamlines fill-finish and packaging process
Optimal protection
2.5B Units Annually
Ancillary safety needle
+
Unifill Platform
Standard Prefill Syringe
Current Safety Syringe
Direct Substitute
Ancillary safety Device
+
Standard Prefill Syringe
Current Safety Syringe
8

9
Success in the Face of a Big Challenge
Technologysolvesatechnicalchallengemostthoughtimpossible
Sanofi invested $40MM for access rights to Unifill
Ready for initial shipment in July – well ahead of original schedule
Current capacity of 60MM units, planned 150MM unit line extension

10
New Paradigm in Drug-Device Development
Clinical Development (phase I, II, III)
Approval
Sales
Patient requirements
Drug industrialization requirements
Customized delivery device
Devicescustomizedtospecificrequirements ofdrugsandtargetpatients
Collaboration with drug companies from clinical development through commercial sales
Unique devices increasingly used to differentiate brands, optimize product lifecycles and enhance patient care

Summary
11
Unilife - emerging global leader in innovative drug delivery devices
Injectable drug delivery device market is attractive and growing fast
Innovative, differentiated devices for pipeline drugs and biosimilars
Developing rich portfolio of technologies driven by customer need
Unifill: the 1st and only prefill syringe system with integrated safety
The new drug-device paradigm is to target pipeline drugs to develop total system solutions for the pharmaceutical partner
LaunchwithUnifill,thendrivegrowthwithsuccessive introductionsofinnovative,differentiateddevices

http://www.proactivenewsroom.com	55
http://www.pitchengine.com	2
http://wordpress	2
http://copyscape.com	1

Unilife Corp ($UNIS) - Innovative Drug Delivery Device Solutions

by ProActive Capital Resources Group

Accessibility

Categories

Upload Details

Usage Rights

4 Embeds 60

Statistics

Unilife Corp ($UNIS) - Innovative Drug Delivery Device Solutions Presentation Transcript